Latest filing published 17 Dec 2019 for Spark Therapeutics, Inc., €1.5M. Read the official filing
Not enough history yet: 0 closed purchases, at least 2 are needed.
Elliot Sigal has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Mead Johnson Nutrition Co and Spark Therapeutics, Inc. Between 26 February 2016 and 17 December 2019, the trades on record add up to 11 filings.
In open-market terms, that means 1 purchase worth €2,224 on one side and 1 sale worth €1,764 on the other. Taken together, the purchases exceed the sales by €460. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 4 option exercises.
Most recently, on 17 December 2019, the filings show a transaction worth €1.5M in Spark Therapeutics, Inc. The last purchase on record was published on 16 April 2018, which is 3,109 days ago. Publication is fast: at least half of the trades appear on SEC (Form 4) on the same day. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 of 10 declarations